IMRX latest filing
Immuneering Corp (IMRX) Latest Insider Activity & Form 4 Trackers
Latest Alert: Zeskind Benjamin J. (PRESIDENT AND CEO) Bought 2,400 Shares of IMRX
SEC Form 4 filings parsed and delivered to your inbox seconds after publication.
⚡ Missed the move? Google takes hours to index these filings, but our direct SEC pipeline delivers alerts instantly. Start your 2-week free trial to receive real-time, real-second email updates whenever IMRX insiders trade.
⚠️ DATA DELAYED BY 48 HOURS
Snapshot updated 2026-09-03T06:31:22.016145Z across 2472 tracked ticker pages.
| Ticker | Filing Date | Company | Insider | Title | Transaction | Shares | Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| IMRX | 2026-06-24 | Immuneering Corp | Zeskind Benjamin J. | PRESIDENT AND CEO | Buy | 2,400 | $4.56 | $10,948.08 | 0.10% | View Filing |
| IMRX | 2026-06-16 | Immuneering Corp | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | Buy | 6,035 | $4.15 | $25,045.25 | 1.58% | View Filing |
Pricing
Free Trial
10 trading days$0
Explore every Premium feature before you pay.
- Full platform access
- 10 trading days
- No credit card required
Standard Monthly
Scheduled$19.99 / month
Scheduled alerts with complete trade context.
- Email and Telegram delivery
- Alert intervals from every sixty minutes to once daily
- Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
- Highlighted cluster transactions and direct SEC filing links
Premium Monthly
Recommended$29.99 / month
Fastest alerts with ticker-level control.
- Everything in Standard
- Instant delivery detection-to-outbound time averages 0.83 seconds
- Alert intervals starting from one minute
- Filter alerts by ticker
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.